HopeStage
Back to all studies
CompletedNCT01411774

Adding D-Cycloserine to CBT for Childhood OCD

About this title

D-cycloserine Augmentation of Cognitive Behavioral Therapy (CBT) for Pediatric Obsessive-compulsive Disorder (OCD)

Read the official source — NCT01411774
Medication studyAges 7–17United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 7 years to 17 years.

Listed locations
St. Petersburg and 1 more locationSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJune 2011
Recruitment status
Completed
Enrollment listed in the registry
142
Sponsor
University of South Florida
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural, Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 7 Years to 17 Years
Official registry ID
NCT01411774
Official title
Show the full official title

1/2 D-cycloserine Augmentation of CBT for Pediatric OCD

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

St. Petersburg · Cambridge

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of South Florida, a university.

Did this study involve medication?

Yes. The study involved medication, including d-cycloserine and Pill placebo.

Who was this study for?

Listed age limits: 7 years to 17 years.

Want to explore more studies?

Explore studies